Diagnosis: Type 1 Diabetes Mellitus (Option A)
This patient has Type 1 diabetes mellitus, confirmed by the combination of classic hyperglycemic symptoms (polydipsia, polyuria), hyperglycemia, elevated HbA1c, and critically, an almost undetectable C-peptide level indicating severe beta-cell destruction. 1
Diagnostic Reasoning
Classic Presentation of Type 1 Diabetes
- The patient presents with polydipsia and polyuria, which are hallmark symptoms of diabetes mellitus caused by osmotic diuresis from hyperglycemia 2, 3
- These classic symptoms combined with hyperglycemia are sufficient for diabetes diagnosis 1, 2
- The 30-year-old age fits the typical adult presentation of Type 1 diabetes, which can occur at any age, even into the 8th and 9th decades 1
C-Peptide: The Critical Distinguishing Feature
- The almost undetectable C-peptide level is the definitive marker that distinguishes Type 1 from Type 2 diabetes 1, 4
- Low or undetectable C-peptide indicates little to no insulin secretion due to autoimmune beta-cell destruction, which is pathognomonic for Type 1 diabetes 1
- In Type 2 diabetes, C-peptide levels are typically normal or elevated due to insulin resistance with preserved beta-cell function 1
Family History Supports Type 1 Diagnosis
- A positive family history of Type 1 diabetes increases the likelihood of autoimmune diabetes due to genetic predisposition with HLA associations 1, 4
- Type 1 diabetes has strong HLA linkage to DQA and DQB genes 1
Elevated HbA1c Confirms Chronic Hyperglycemia
- The elevated HbA1c confirms the diagnosis of diabetes and indicates significant sustained hyperglycemia 1, 4
- Combined with symptoms and glucose elevation, this meets ADA diagnostic criteria 1
Why Not the Other Options?
Type 2 Diabetes (Option B) - Excluded
- Type 2 diabetes would show normal or elevated C-peptide due to insulin resistance with preserved or increased insulin secretion 1
- The almost absent C-peptide definitively rules out Type 2 diabetes 1, 4
Hyperparathyroidism (Option C) - Concurrent but Not Primary Diagnosis
- While the elevated PTH indicates concurrent primary hyperparathyroidism, this does not explain the polydipsia, polyuria, or undetectable C-peptide 4
- Hyperparathyroidism can cause glucose intolerance through insulin resistance and hypercalcemia, but it causes insulin hypersecretion (elevated C-peptide), not the severe insulin deficiency seen here 5, 6
- The coexistence of Type 1 diabetes and primary hyperparathyroidism can worsen glucose control, but the primary diagnosis driving the symptoms is Type 1 diabetes 4
Diabetes Insipidus (Option D) - Excluded
- Diabetes insipidus causes polydipsia and polyuria but is characterized by dilute urine and normal glucose metabolism 1
- The presence of hyperglycemia, elevated HbA1c, and undetectable C-peptide completely excludes diabetes insipidus 1
Clinical Implications
Immediate Management Required
- Initiate insulin therapy immediately, as Type 1 diabetes requires exogenous insulin due to absolute insulin deficiency 4
- The patient is at risk for diabetic ketoacidosis given the severe beta-cell destruction 1
Address Concurrent Hyperparathyroidism
- Evaluate the hyperparathyroidism for surgical candidacy, as corrected calcium >1 mg/dL above upper limit of normal is a surgical indication 4
- Parathyroidectomy may improve glucose control in 37-77% of diabetic patients with concurrent hyperparathyroidism 4
- The hyperparathyroidism may be worsening glucose control through calcium-mediated insulin resistance 4, 5